De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
NCT ID: NCT06934564
Last Updated: 2025-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
16 participants
INTERVENTIONAL
2025-04-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
De-implementing Low Value Preoperative Care Wisely
NCT05566327
Reducing Low-Value Preoperative Investigations in Patients Undergoing Low Risk Surgery
NCT05526495
Personalized Perioperative Care Based on Patient Reported Outcomes Measures
NCT06182254
Post-Surgical Based Efforts to Reduce Preventable Readmissions and Optimize Length of Stay
NCT04881708
Evaluation of the Effectiveness of a Multimedia Information Site in Reducing Preoperative Anxiety in Vascular Surgery Patients.
NCT05717296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wave 1
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases.
Intervention is Year 1 Quarter 2
Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Wave 2
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases.
Intervention is Year 1 Quarter 3
Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Wave 3
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases.
Intervention is Year 1 Quarter 4
Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Wave 4
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases.
Intervention is Year 2 Quarter 1
Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Wave 5
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases.
Intervention is Year 2 Quarter 2
Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Wave 6
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases.
Intervention is Year 2 Quarter 3
Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Surgical participants must be over 18 years old.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Blue Cross Blue Shield of Michigan Foundation
OTHER
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lesly Ann Dossett
Research Professor of Cancer Quality Improvement
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lesly Dossett, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Hari Nathan, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan and other Michigan Surgical Quality Collaborative sites
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00261786
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.